Does Kurt Emster invest in AI startups?

Yes. Artificial Intelligence is one of the sectors on Kurt Emster's investor profile, together with Biotech & Pharma and Healthcare & Biotech. The stages on record are Series B.

Which companies has Kurt Emster backed?

The record lists 78 deals, including Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and CRISPR Therapeutics. None of them has a perk listed on AI Perks yet.

What credits can a startup claim before pitching Kurt Emster?

For a company raising a Series B round, AI Perks lists credits such as Agora (up to $5,000), Attio (up to $5,000), CrowdStrike (up to $10,000) and Datadog (up to $100,000), with each program's terms and how to apply.

Does AI Perks publish investor contact details?

No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.

Kurt Emster

Managing Partner, Head of Life Sciences at Abingworth · Menlo Park, United States

Invests in AI

Kurt Emster's investor profile lists AI alongside Biotech & Pharma and Healthcare & Biotech, at Series B. The record holds 78 deals, among them Kesios Therapeutics, Spruce Biosciences and Amarin.

Email Investor

Credits to line up before a Series B round

Kurt Emster backs companies at Series B. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

Kesios Therapeutics
Spruce Biosciences
Amarin
Syntaxin
CRISPR Therapeutics
Attenua
Broncus Technologies
Trishula Therapeutics, Inc.
Aurinia Pharmaceuticals
Jasper Therapeutics
Synosia Therapeutics
X4 Pharmaceuticals
Orbus Therapeutics
Kspine
Zogenix
PrimeraDx (Primera Biosystems)
Scorpion Therapeutics
Avila Therapeutics
Personalis
MD On-Line
GenSight Biologics
Dicerna Pharmaceuticals
Verona Pharma
Micromet
Proteon Therapeutics
Prosensa
Stanmore Implants Worldwide
GTx
Somaxon Pharmaceuticals
Median Technologies
Valeritas
Soleno Therapeutics
Wilson Therapeutics
Tizona Therapeutics, Inc.
Chroma Therapeutics
Avillion
Hydra Biosciences
Algeta
CymaBay Therapeutics
Sientra
SFJ Pharmaceuticals, Inc.
Intellikine
Chiasma
Gynesonics
Reneo Pharmaceuticals
Cytos Biotechnology
Vera Therapeutics
Portola Pharmaceuticals
Iambic Therapeutics
Facet Biotech

Showing 50 of 78 deals on record.

Investment focus

Backs startups in: Artificial Intelligence, Biotech & Pharma, Healthcare & Biotech
Rounds: Series B
Profile: Venture investor
Deals on record: 78
Based in: Menlo Park, United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Kurt Emster invest in AI startups?: Yes. Artificial Intelligence is one of the sectors on Kurt Emster's investor profile, together with Biotech & Pharma and Healthcare & Biotech. The stages on record are Series B.
Which companies has Kurt Emster backed?: The record lists 78 deals, including Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and CRISPR Therapeutics. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Kurt Emster?: For a company raising a Series B round, AI Perks lists credits such as Agora (up to $5,000), Attio (up to $5,000), CrowdStrike (up to $10,000) and Datadog (up to $100,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?: No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor
Email Investor
Your full name

Source: public professional information. Is this you? Request removal